Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 11:9:F1000 Faculty Rev-177.
doi: 10.12688/f1000research.21625.1. eCollection 2020.

Recent advances in understanding chemotherapy-induced peripheral neuropathy

Affiliations
Review

Recent advances in understanding chemotherapy-induced peripheral neuropathy

Richard Gordon-Williams et al. F1000Res. .

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a common cause of pain and poor quality of life for those undergoing treatment for cancer and those surviving cancer. Many advances have been made in the pre-clinical science; despite this, these findings have not been translated into novel preventative measures and treatments for CIPN. This review aims to give an update on the pre-clinical science, preventative measures, assessment and treatment of CIPN.

Keywords: Chemotherapy; Neuropathy; Pain; Survivorship.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

References

    1. Arnold M, Rutherford MJ, Bardot A, et al. : Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–505. 10.1016/S1470-2045(19)30456-5 - DOI - PMC - PubMed
    1. Brown M, Farquhar-Smith P: Pain in cancer survivors; filling in the gaps. Br J Anaesth. 2017;119(4):723–36. 10.1093/bja/aex202 - DOI - PubMed
    1. Mols F, Beijers T, Vreugdenhil G, et al. : Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22(8):2261–9. 10.1007/s00520-014-2255-7 - DOI - PubMed
    1. Seretny M, Currie GL, Sena ES, et al. : Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461–70. 10.1016/j.pain.2014.09.020 - DOI - PubMed
    1. Gutiérrez-Gutiérrez G, Sereno M, Miralles A, et al. : Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin Transl Oncol. 2010;12(2):81–91. 10.1007/S12094-010-0474-z - DOI - PubMed

MeSH terms